{"id":46304,"date":"2025-12-05T11:31:53","date_gmt":"2025-12-05T10:31:53","guid":{"rendered":"https:\/\/www.idisantiago.es\/grupo-de-investigacion\/neurohula\/"},"modified":"2026-04-13T13:55:34","modified_gmt":"2026-04-13T11:55:34","slug":"neurohula","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/gl\/grupo-de-investigacion\/neurohula\/","title":{"rendered":"NeuroHULA"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.idisantiago.es\/gl\/grupos-de-investigacion\/\"><strong>GRUPOS DE INVESTIGACI\u00d3N<\/strong><\/a><\/p>\n<h1>Grupo de Investigaci\u00f3n Unidade de Mama Hospitalaria Lucus Augusti<\/h1>\n<p>&nbsp;<\/p>\n<p>CATEGOR\u00cdA: <span style=\"color: #003366;\">GRUPOS COLABORADORES<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image title_text=&#8221;IMG-20230418-WA0000&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_toggle title=&#8221;Obxectivos e li\u00f1as de investigaci\u00f3n&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Objetivos y l\u00edneas de investigaci\u00f3n&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h3>Obxectivos<\/h3>\n<p>Estudo de potenciais estratexias diagn\u00f3sticas e terap\u00e9uticas en enfermidades neurol\u00f3xicas para a s\u00faa futura utilizaci\u00f3n na pr\u00e1ctica cl\u00ednica habitual.<\/p>\n<p>&nbsp;<\/p>\n<h3>Li\u00f1as de investigaci\u00f3n<\/h3>\n<ul>\n<li>Diagn\u00f3stico precoz, biomarcadores e tratamento da enfermidade de Alzheimer e outras demencias.<\/li>\n<li>Biomarcadores diagn\u00f3sticos e pron\u00f3sticos da enfermidade cerebrovascular.<\/li>\n<li>Diagn\u00f3stico, biomarcadores e tratamento da epilepsia.<\/li>\n<li>Biomarcadores, diagn\u00f3stico e tratamento en esclerose m\u00faltiple.<\/li>\n<li>Biomarcadores, diagn\u00f3stico e tratamento da migra\u00f1a.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Equipo investigador&#8221; admin_label=&#8221;Equipo investigador&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<table style=\"width: 100%; border-collapse: collapse; border-style: hidden;\" border=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 50%;\">\n<p><strong>L\u00edder<\/strong><br \/>Pego Reigosa, Robustiano<\/p>\n<p><strong>Membros<\/strong><br \/>Bermello L\u00f3pez, Lourdes<br \/>Corredoira L\u00f3pez, Sara<br \/>Fern\u00e1ndez Cabrera, Alejandro<br \/>Figueira G\u00f3mez, Ant\u00eda<br \/>Rodr\u00edguez Ares, Tania<br \/>V\u00e1zquez L\u00f3pez, Esther<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<\/td>\n<td style=\"width: 50%;\">\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Proxectos&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Proyectos (cambiar s\u00f3 codigo IDIS)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>Estudio Observacional para evaluar el cumplimiento terap\u00e9utico de los pacientes con esclerosis m\u00faltiple en tratamiento con terapias modificadoras de la enfermedad de primera l\u00ednea. Estudio Compliance. E-0232. NOV-TME-2010-01.<br \/>Estudio de biomarcadores en LCR para el diagn\u00f3stico de EA prodr\u00f3mica en pacientes con deterioro cognitivo ligero. Estudio PREDEM. ENOSM\/2012\/01. NOV-SNC-2011-01.<br \/>Estudio observacional, prospectivo, multinacional, multic\u00e9ntrico, que compara la efectividad de Safinamida, Rasagilina y otros \u201ctratamientos est\u00e1ndar\u201d como tratamiento complementario a la levodopa (L-dopa) en pacientes con enfermedad de Parkinson (EP) fluctuante. E-2203. Z7219N04 (ZAM-SAF-2019-01).<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Publicaci\u00f3ns&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Publicaciones&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li>R Pego-Reigosa, S L\u00f3pez-L\u00f3pez, ME V\u00e1zquez-L\u00f3pez, V Armesto-P\u00e9rez, F Bra\u00f1as-Fern\u00e1ndez, F Mart\u00ednez-V\u00e1zquez, R Pi\u00f1eiro-Bola\u00f1o, JA Cort\u00e9s-La\u00ed\u00f1o. <strong>Sea wave-induced internal carotid artery dissection<\/strong>. <em>Neurology<\/em> 2005 Jun 14; 64(11):1980. <span class=\"identifier doi\"><span class=\"id-label\">: <span style=\"color: #808000;\"><strong>doi: <\/strong><\/span><\/span><span style=\"color: #808000;\"><strong><a class=\"id-link\" style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1212\/01.wnl.0000163855.78628.42\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\">10.1212\/01.WNL.0000163855.78628.42<\/a><\/strong><\/span><\/span><\/li>\n<li>Pego-Reigosa R, V\u00e1zquez-L\u00f3pez ME, Iglesias-G\u00f3mez S, Martinez-V\u00e1zquez F. <strong>Association between chronic paroxysmal hemicrania and primary trochlear headache: pathophysiology and treatment<\/strong>. <em>Cephalalgia<\/em> 2006; 26 (10): 1252-1254. <span style=\"color: #808000;\"><strong>doi<span class=\"identifier doi\"><span class=\"id-label\">:\u00a0<\/span><a class=\"id-link\" style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01202.x\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\">10.1111\/j.1468-2982.2006.01202.x<\/a><\/span><\/strong><\/span><\/li>\n<li>Mu\u00f1oz D, Escart\u00edn A, Dapena D, Coret F, Fern\u00e1ndez-Ur\u00eda D, P\u00e9rez D, Casanova B, Guijarro-Castro C, Munteis E, del-Campo Amigo M, Pego R, Calles C, Garc\u00eda-Rey C, Monsalve N, S\u00e1nchez-Matienzo D. <strong>Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers<\/strong>. <em>BMC Neurol<\/em>. 2013 Jul 11;13 :82. <strong><span style=\"color: #808000;\">doi<span class=\"identifier doi\"><span class=\"id-label\">: <\/span><a class=\"id-link\" style=\"color: #808000;\" href=\"https:\/\/doi.org\/10.1186\/1471-2377-13-82\" target=\"_blank\" rel=\"noopener\" data-ga-category=\"full_text\" data-ga-action=\"DOI\">10.1186\/1471-2377-13-82<\/a><\/span><\/span><\/strong><\/li>\n<li>Alberte-Woodward M, da Silva-Fran\u00e7a CF, Rodr\u00edguez-Gay I, Pego-Reigosa R. <strong>Safety of Intravenous Thrombolysis for Acute Stroke in Patients with an Active Malignancy: Case Series and Review of the Literature<\/strong>. <em>Eur Neurol.<\/em> 2019;81(3-4): 163-166.<\/li>\n<li>Fern\u00e1ndez-Cabrera A, Garc\u00eda-De Soto J, Pego-Reigosa R, Su\u00e1rez-Quintanilla J. <strong>Relationship between periodontitis and cerebral atrophy: A cross-sectional study.<\/strong> <em>Dent Med Probl.<\/em> 2025 May-Jun;62(3): 493-498.<\/li>\n<li>Garc\u00eda-de Soto J, Castro-Mosquera M, Pouso-Diz JM, Fern\u00e1ndez-Cabrera A, Rodr\u00edguez-Arrizabalaga M, Debasa-Mouce M, Camino-Casti\u00f1eiras J, Minguill\u00f3n Pereiro AM,<\/li>\n<li>Aramburu-N\u00fa\u00f1ez M, Romaus-Sanjurjo D, Aldrey JM, Pego-Reigosa R, P\u00edas-Peleteiro JM, Sobrino T, Ouro A. <strong>Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer&#8217;s Disease: From Molecular Mechanisms to Therapeutic Potential.<\/strong> <em>Int J Mol Sci.<\/em> 2025 Jul 23;26(15): 7068.<\/li>\n<li>Fern\u00e1ndez-Cabrera A, Santamar\u00eda-Montero P, Garc\u00eda de-Soto J, Pego-Reigosa R. <strong>MonoPER study: Effectiveness and tolerability of PERampanel in monotherapy in real-world after 12 months of treatment.<\/strong> <em>Epilepsia Open<\/em>. 2025 Oct;10(5): 1587-1594.<\/li>\n<li>Fern\u00e1ndez-Cabrera A, Santamar\u00eda-Montero P, Soto JG, Figueira-G\u00f3mez A, Rodr\u00edguez-Botana M, P\u00e9rez-Regojo B, Pego-Reigosa R. <strong>EPIDEP: Prevalence of undiagnosed depression in an epilepsy outpatient clinic.<\/strong> <em>Epilepsy Behav Rep.<\/em> 2025 Aug 9;32:100819.<\/li>\n<\/ul>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Web del grupo&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Web del grupo&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>https:\/\/<\/p>\n<p>[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Investigador l\u00edder<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-43607\" class=\"sp-team-pro sptp-section sptp-new_page pagination_normal sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"43598\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar \"  href=https:\/\/www.idisantiago.es\/team\/robustiano-pego-reigosa\/ target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"43598\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2025\/12\/Pego-320x320.jpg\" src=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2025\/12\/Pego-320x320.jpg\" alt=\"Robustiano Pego Reigosa\" width=\"320\" height=\"320\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tRobustiano Pego Reigosa\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>robustiano.pego.reigosa@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-member-phone\">\n<i class=\"fa fa-phone\"><\/i>\t<a href=\"#0\"  class=\"\" >\n\t\t<span>982296698<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-member-website\">\n<i class=\"fa fa-globe\"><\/i>\t<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Pego-Reigosa+r&#038;sort=date&#038;size=200\"  class=\"\" target=\"_blank\">\n\t\t<span>https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Pego-Reigosa+r&amp;sort=date&amp;size=200<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-read-more-button\">\n\t<a class=\"sptp-member-read-more-button\" href=\"https:\/\/www.idisantiago.es\/team\/robustiano-pego-reigosa\/\"> + INFO <\/a>\n<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; GRUPOS DE INVESTIGACI\u00d3N Grupo de Investigaci\u00f3n Unidade de Mama Hospitalaria Lucus Augusti &nbsp; CATEGOR\u00cdA: GRUPOS COLABORADORESObxectivos Estudo de potenciais estratexias diagn\u00f3sticas e terap\u00e9uticas en enfermidades neurol\u00f3xicas para a s\u00faa [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":10312,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[891],"project_tag":[],"class_list":["post-46304","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-grupos-colaboradores-gl"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/46304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/comments?post=46304"}],"version-history":[{"count":3,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/46304\/revisions"}],"predecessor-version":[{"id":46320,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project\/46304\/revisions\/46320"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media\/10312"}],"wp:attachment":[{"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/media?parent=46304"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_category?post=46304"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.idisantiago.es\/gl\/wp-json\/wp\/v2\/project_tag?post=46304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}